Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture

被引:99
作者
Stoll, S
Garner, W
Elder, J
机构
[1] UNIV MICHIGAN,DEPT DERMATOL,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,DEPT SURG,ANN ARBOR,MI 48109
[3] UNIV MICHIGAN,DEPT RADIAT ONCOL CANC BIOL,ANN ARBOR,MI 48109
关键词
wound healing; skin; receptor protein tyrosine kinase; epidermal growth factor urogastrone receptor; transforming growth factor alpha;
D O I
10.1172/JCI119641
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Exogenous EGF and TGF-alpha accelerate wound healing, but treatment effects are often modest. Using short-term human skin organ culture, we found that autocrine EGF receptor activation could account for this observation. Amphiregulin and heparin-binding EGF-like growth factor (HB-EGF) transcripts were rapidly and markedly induced, whereas EGF and TGF-alpha mRNAs were undetectable or only slightly increased, Vascular permeability factor and keratin 6 transcripts were also strongly induced, albeit with a greater than or equal to 3 h delay relative to HB-EGF and amphiregulin. All four transcripts were upregulated in actual healing skin wounds, HB-EGF and keratin 6 being the most prominent, The highly EGF receptor-specific tyrosine kinase inhibitor PD153035 strongly inhibited induction of all four transcripts in organ culture, as well as release of immunoreactive HB-EGF into the medium. These effects were confirmed using the anti-EGF receptor mAb 225 IgG. Neither PD153035 nor 225 IgG was toxic to keratinocytes, as judged by calcein-AM uptake, PD153035 completely abrogated the proliferative phase of keratinocyte outgrowth in skin explant cultures, whereas it had no effect on the antecedent migratory phase. Based on these results, we conclude that EGF receptor activation by highly inducible, keratinocyte-derived heparin-binding ligands is an important mechanism for amplification and transmission of the cutaneous wound healing signal.
引用
收藏
页码:1271 / 1281
页数:11
相关论文
共 59 条
[1]  
[Anonymous], 2014, SCI TRANSL MED, DOI DOI 10.1126/scitranslmed.3009337
[2]  
Ausubel F.M., 1988, CURRENT PROTOCOLS MO, V1
[3]  
BARNARD JA, 1994, J BIOL CHEM, V269, P22817
[4]  
BEERLI RR, 1995, MOL CELL BIOL, V15, P6496
[5]   EFFECT OF GROWTH-FACTORS ON CELL-PROLIFERATION AND EPITHELIALIZATION IN HUMAN SKIN [J].
BHORA, FY ;
DUNKIN, BJ ;
BATZRI, S ;
ALY, HM ;
BASS, BL ;
SIDAWY, AN ;
HARMON, JW .
JOURNAL OF SURGICAL RESEARCH, 1995, 59 (02) :236-244
[6]   ENHANCEMENT OF WOUND-HEALING BY TOPICAL TREATMENT WITH EPIDERMAL GROWTH-FACTOR [J].
BROWN, GL ;
NANNEY, LB ;
GRIFFEN, J ;
CRAMER, AB ;
YANCEY, JM ;
CURTSINGER, LJ ;
HOLTZIN, L ;
SCHULTZ, GS ;
JURKIEWICZ, MJ ;
LYNCH, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (02) :76-79
[7]   Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency [J].
Bugge, TH ;
Kombrinck, KW ;
Flick, MJ ;
Daugherty, CC ;
Danton, MJS ;
Degen, JL .
CELL, 1996, 87 (04) :709-719
[8]  
CARPENTER G, 1990, J BIOL CHEM, V265, P7709
[9]  
COFFEY RJ, 1992, CELL GROWTH DIFFER, V3, P347
[10]   PRODUCTION AND AUTOINDUCTION OF TRANSFORMING GROWTH FACTOR-ALPHA IN HUMAN KERATINOCYTES [J].
COFFEY, RJ ;
DERYNCK, R ;
WILCOX, JN ;
BRINGMAN, TS ;
GOUSTIN, AS ;
MOSES, HL ;
PITTELKOW, MR .
NATURE, 1987, 328 (6133) :817-820